Univest
Univest
  • Markets

Mphasis Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

  • June 25, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Mphasis Q1 Results

Mphasis Q1 Results FY27: Uniresearch projects Revenue Rs 4,247 Cr | PAT Rs 517 Cr (36-analyst consensus). Q4 FY26: Rev Rs 4,243 Cr | PAT Rs 510 Cr.

The Mphasis Q1 Results FY27 outlook is anchored on Q4 FY26 verified actuals and Uniresearch analysis applying the 36-analyst FY27 consensus to Q1 FY26 verified actuals. Uniresearch projects Revenue Rs 4,247 Cr (+13.8% YoY) and PAT Rs 517 Cr (+16.9% YoY). Prepared by Kunal Singla.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Mphasis Q1 Results FY27 – Uniresearch Prediction
  • Mphasis Q4 FY26 Key Metrics – Baseline for Mphasis Q1 Results FY27
  • What Analysts Are Saying About Mphasis
  • Key Watchpoints for Mphasis
    • Revenue Delivery vs Consensus for Mphasis
    • PAT Performance in Q1 Results FY27
  • Risks to the Mphasis Prediction
    • Below-Consensus Revenue Growth
    • PAT Pressure in Q1 Results FY27
  • Conclusion: Mphasis
  • Frequently Asked Questions on Mphasis
    • What is Uniresearch’s PAT prediction for Mphasis Q1 Results FY27?
    • What is the Revenue prediction for Mphasis Q1 Results FY27?
    • What were Mphasis Q1 Results FY27?
    • Does the Mphasis Q1 Results FY27?
    • What is the analyst target price mentioned in the Mphasis Q1 Results FY27?
    • What are the risks to the Mphasis Q1 Results FY27?
    • What is the Q1 FY26 base for the Mphasis Q1 Results FY27?

Mphasis Q1 Results FY27 – Uniresearch Prediction

Metric Q1 FY26 Actual Q1 Results FY27 Uniresearch Prediction YoY Change Source
Mphasis Revenue (Rs Cr) 3,732 4,247 +13.8% Uniresearch | 36-analyst consensus applied to Q1 FY26 verified actual
PAT (Rs Cr) 442 517 +16.9% Uniresearch | 36-analyst consensus applied to Q1 FY26 verified actual
Avg Analyst Target Rs 2,646 12-month view – Analyst consensus (36 analysts)

Predictions apply 36-analyst FY27 consensus (Rev +13.8%, PAT +16.9%) to Q1 FY26 verified actuals. Not guaranteed outcomes.

Mphasis Q4 FY26 Key Metrics – Baseline for Mphasis Q1 Results FY27

Metric Q4 FY26 Actual YoY Change Source
Revenue (Rs Cr) 4,243 +14.4% YoY Consolidated quarterly financial data
PAT (Rs Cr) 510 +14.3% YoY Consolidated quarterly financial data

What Analysts Are Saying About Mphasis

Across 36 analysts covering Mphasis, the FY27 consensus projects revenue growth of +13.8% and profit growth of +16.9%, with an average 12-month price target of Rs 2,646. The Q1 Results FY27 prediction reflects this consensus applied to verified Q1 FY26 actuals.

Key Watchpoints for Mphasis

Revenue Delivery vs Consensus for Mphasis

The primary watchpoint is whether Revenue in Q1 Results FY27 delivers in line with the Uniresearch projection of Rs 4,247 Cr (+13.8% consensus growth). Q1 FY26 base was Rs 3,732 Cr.

PAT Performance in Q1 Results FY27

The PAT watchpoint is whether Mphasis achieves Rs 517 Cr (+16.9% growth from Q1 FY26 base of Rs 442 Cr). Q4 FY26 PAT was Rs 510 Cr.

Risks to the Mphasis Prediction

Below-Consensus Revenue Growth

If Revenue comes in below the +13.8% consensus, actual revenue would fall short of Rs 4,247 Cr.

PAT Pressure in Q1 Results FY27

The PAT prediction of Rs 517 Cr could be impacted by cost escalation not factored into the 36-analyst consensus of +16.9%.

Conclusion: Mphasis

The Mphasis Uniresearch prediction of Revenue Rs 4,247 Cr and PAT Rs 517 Cr is derived from the 36-analyst consensus FY27 growth rates applied to verified Q1 FY26 actuals. When Q1 Results FY27 are declared, investors can benchmark actual performance against this consensus prediction. Track live updates on Univest.

Track Mphasis Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live Q1 Results FY27 alerts.

Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals – these are analyst consensus projections and are not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.

Frequently Asked Questions on Mphasis

What is Uniresearch’s PAT prediction for Mphasis Q1 Results FY27?

Ans. Uniresearch projects Mphasis Q1 Results PAT at Rs 517 Cr, applying 36-analyst FY27 profit growth consensus of +16.9% to Q1 FY26 verified PAT of Rs 442 Cr.

What is the Revenue prediction for Mphasis Q1 Results FY27?

Ans. Mphasis Q1 Results Revenue is projected at Rs 4,247 Cr, applying +13.8% FY27 revenue consensus to verified Q1 FY26 base.

What were Mphasis Q1 Results FY27?

Ans. Q4 FY26 consolidated Revenue was Rs 4,243 Cr (+14.4% YoY) and PAT was Rs 510 Cr (+14.3% YoY).

Does the Mphasis Q1 Results FY27?

Ans. No. All predictions in this article are derived from the 36-analyst consensus applied to verified Q1 FY26 actuals.

What is the analyst target price mentioned in the Mphasis Q1 Results FY27?

Ans. The 36-analyst consensus gives an average 12-month price target of Rs 2,646 for Mphasis.

What are the risks to the Mphasis Q1 Results FY27?

Ans. Risks include below-consensus revenue growth (target: +13.8%) and unexpected cost pressures impacting the +16.9% PAT consensus.

What is the Q1 FY26 base for the Mphasis Q1 Results FY27?

Ans. Q1 FY26 consolidated Revenue was Rs 3,732 Cr and PAT was Rs 442 Cr. These form the base for the Mphasis Q1 Results prediction.



News Q1 results
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply